Evicenter
P&T meetings

SL1009 (sodium dichloroacetate)

Pyruvate dehydrogenase complex deficiency

Manufacturer
Saol Therapeutics
Regulatory submission
NDA resubmitted June 2026
Launch
Not announced
Last updated
78 sources

Product information and disease descriptionPlace of product in therapyDisease descriptionBurden of Pyruvate dehydrogenase complex deficiency

Economic impact of diagnostic testing

1 evidence topic · 1 source

SL1009 dose-determining genetic test cost

No evidence found.